CHARLOTTE, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), today announced the voluntary suspension of sales and marketing of its Byte ...

The product, heavily marketed on social media, is one of more than 28,000 medical devices the regulator considers so low-risk they barely warrant scrutiny.

Oct 24 (Reuters) - (This Oct. 24 story has been corrected to say that Dentsply Sirona suspended sales of its 'Byte' teeth aligners, not all aligners in the headline) Dentsply Sirona (XRAY.O), opens ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

On Oct. 24, no-moat Dentsply Sirona unexpectedly announced that it has voluntarily suspended the sale and marketing of Byte aligners and impression kits after consulting with the Food and Drug ...

Dentsply Sirona (NASDAQ:XRAY) announced on Tuesday that it plans to refocus its Byte business model to emphasize treatments ...

Dentsply Sirona, Inc. XRAY has voluntarily suspended sales and marketing of its Byte Aligners and Impression Kits as part of a regulatory review with the FDA. During this suspension, shipments and new ...